Secondary Progressive Multiple Sclerosis Drug Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
May 2019
62
About the Report
About the Report
According to 99Strategy, the Global Secondary Progressive Multiple Sclerosis Drug Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Secondary Progressive Multiple Sclerosis Drug market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AB Science SA
Actelion Ltd
Biogen, Inc.
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Immune Response BioPharma, Inc.
Innate Immunotherapeutics Ltd
Kyorin Pharmaceutical Co., Ltd.
Mallinckrodt Plc
MedDay SA
MedImmune, LLC
Merck KGaA
Meta-IQ ApS
Novartis AG
Opexa Therapeutics, Inc.
Xenetic Biosciences (UK) Limited
Key Product Type
Inebilizumab
GLX-1112
DC-TAB
Etomoxir
IB-MS
Others
Market by Application
Hospital
Clinic
Others
Main Aspects covered in the Report
Overview of the Secondary Progressive Multiple Sclerosis Drug market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Products
Table of Contents
Table of Contents
Table of Content
1 Industrial Chain Overview
1.1 Secondary Progressive Multiple Sclerosis Drug Industry
1.1.1 Overview
1.1.2 Characteristics of Secondary Progressive Multiple Sclerosis Drug
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Inebilizumab
1.3.2 GLX-1112
1.3.3 DC-TAB
1.3.4 Etomoxir
1.3.5 IB-MS
1.3.6 Others
1.4 End-Use List
1.4.1 Demand in Hospital
1.4.2 Demand in Clinic
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 AB Science SA Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Actelion Ltd Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Biogen, Inc. Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 F. Hoffmann-La Roche Ltd. Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Genzyme Corporation Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Glialogix, Inc. Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Immune Response BioPharma, Inc. Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Innate Immunotherapeutics Ltd Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Kyorin Pharmaceutical Co., Ltd. Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Mallinckrodt Plc Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 MedDay SA Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 MedImmune, LLC Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Merck KGaA Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Meta-IQ ApS Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Novartis AG Overview
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Opexa Therapeutics, Inc. Overview
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Xenetic Biosciences (UK) Limited Overview
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Inebilizumab
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in GLX-1112
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in DC-TAB
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Etomoxir
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in IB-MS
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.2.6 Market in Others
5.2.6.1 Market Size
5.2.6.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospital
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinic
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
10 Research Conclusion
List of Figure
Figure Secondary Progressive Multiple Sclerosis Drug Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Inebilizumab , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Inebilizumab , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in GLX-1112 , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in GLX-1112 , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in DC-TAB , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in DC-TAB , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Etomoxir , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Etomoxir , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in IB-MS , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in IB-MS , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
List of Table
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table AB Science SA Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of AB Science SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Actelion Ltd Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Actelion Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Biogen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Genzyme Corporation Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Genzyme Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Glialogix, Inc. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Glialogix, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Immune Response BioPharma, Inc. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Immune Response BioPharma, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Innate Immunotherapeutics Ltd Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Innate Immunotherapeutics Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Kyorin Pharmaceutical Co., Ltd. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Kyorin Pharmaceutical Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Mallinckrodt Plc Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Mallinckrodt Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table MedDay SA Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of MedDay SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of MedImmune, LLC (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Merck KGaA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Meta-IQ ApS Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Meta-IQ ApS (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Opexa Therapeutics, Inc. Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Opexa Therapeutics, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Xenetic Biosciences (UK) Limited Overview List
Table Secondary Progressive Multiple Sclerosis Drug Business Operation of Xenetic Biosciences (UK) Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.